In a release issued under the same headline earlier today by Mersana Therapeutics, Inc. (NASDAQ: MRSN), please note that there was a transcription error in the last cell of the first table. The Median OS should have been 5.7 months rather than 1.7 months. The corrected release follows:
CORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results
Seeking Alpha / 1 hour ago 1 Views
Comments